PAVmed(PAVM) - 2024 Q2 - Quarterly Results

Exhibit 99.1 PAVmed Provides Business Update and Second Quarter 2024 Financial Results Lucid reports record quarterly EsoGuardtest volume and held productive meeting with CMS Medicare Administrative Contractor (MAC) Palmetto GBA's MolDX Program Veris Health actively pursuing financing following launch of pilot program with The Ohio State's James Cancer Hospital Conference call and webcast to be held today, August 13 at 8:30 AM EDT NEW YORK, August 13, 2024 - PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or th ...